Figures & data
Table 1 In vitro growth inhibitory activity of BS-181 on gastric cancer and normal cell lines
Figure 1 BS-181 decreased the migration and invasion ability of BGC823 cells.
![Figure 1 BS-181 decreased the migration and invasion ability of BGC823 cells.](/cms/asset/73fc7633-2770-4815-a70b-40e22058f7f5/dddt_a_12177687_f0001_b.jpg)
Figure 2 BS-181 induced cell apoptosis (A) and regulated apoptosis-related protein expressions (B and C).
![Figure 2 BS-181 induced cell apoptosis (A) and regulated apoptosis-related protein expressions (B and C).](/cms/asset/df27c5e8-cb8f-425c-9f25-0167cb3e34ce/dddt_a_12177687_f0002_b.jpg)
Figure 3 BS-181-impaired cell cycle progression in BGC823 cells.
![Figure 3 BS-181-impaired cell cycle progression in BGC823 cells.](/cms/asset/0cf51de2-07c5-4b25-a58f-a96114d91450/dddt_a_12177687_f0003_c.jpg)
Table 2 Inhibition of cyclin-dependent protein kinase activity by BS-181
Figure 4 BS-181-inhibited phosphorylation of CDK7 substrates.
![Figure 4 BS-181-inhibited phosphorylation of CDK7 substrates.](/cms/asset/688d7ae7-2e97-4109-abe9-5a77b80824a4/dddt_a_12177687_f0004_b.jpg)
Figure 5 BS-181-inhibited gastric cancer growth in vivo and increased survival rate.
![Figure 5 BS-181-inhibited gastric cancer growth in vivo and increased survival rate.](/cms/asset/ddce2ed6-e23d-47e7-bd87-d9c91a038e4c/dddt_a_12177687_f0005_c.jpg)